FIGURE 2 Three HIV protease inhibitors used in the treatment of HIV infection. The hydroxyl group (light red) is designed to mimic the tetrahedral transition state of the enzyme-catalyzed reaction shown in Figure 1. The aromatic groups (beige) are designed to fit into other pockets on the surface of the enzyme.